Jincheng Pharm(300233.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Jincheng Pharm
300233.SZ
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.
2.805 T
300233.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking127/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE1.79%C
    • Profit Margin2.42%C
    • Gross Margin34.61%C
  • Growth ScoreD
    • Revenue YoY-12.59%E
    • Net Profit YoY-55.04%D
    • Total Assets YoY-4.76%D
    • Net Assets YoY-0.76%D
  • Cash ScoreC
    • Cash Flow Margin621.14%A
    • OCF YoY-12.59%E
  • Operating ScoreC
    • Turnover0.52C
  • Debt ScoreB
    • Gearing Ratio27.38%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    A-share Three Major Indices Fell Collectively, Computing Hardware Active Against the Trend, Hang Seng Tech Index Down Over 1%, AI Large Model Stocks Rebound, KNOWLEDGE ATLAS Rises 7%

    Wallstreetcn·
    HK
    02513
    -0.39%
    SZ
    002793
    +2.56%
    SZ
    002589
    -2.30%
    Wallstreetcn·
    HK
    02513
    -0.39%
    SZ
    002793
    +2.56%
    SZ
    002589
    -2.30%

    Jincheng Pharm: Subsidiary products are expected to be selected for the 11th batch of national centralized drug procurement

    Zhitong·
    SZ
    300233
    -1.06%
    Zhitong·
    SZ
    300233
    -1.06%

    Jincheng Pharm: Morphine Nitrazepam Sodium Injection has obtained a drug registration certificate

    Zhitong·
    SZ
    300233
    -1.06%
    Zhitong·
    SZ
    300233
    -1.06%

    Jincheng Pharm: Subsidiary receives approval notice for drug supplementary application

    Zhitong·
    SZ
    300233
    -1.06%
    Zhitong·
    SZ
    300233
    -1.06%

    A-share innovative drug concept stocks fluctuated lower, with BETTA PHARMACEUTICALS falling over 10%, Jincheng Pharm, Konruns, Baillie Tianheng, Olymvax Biopharmaceuticals, and CCHT all dropping more than 5%

    Zhitong·
    SZ
    300233
    -1.06%
    SZ
    000661
    -2.87%
    SZ
    300558
    +0.33%
    Zhitong·
    SZ
    300233
    -1.06%
    SZ
    000661
    -2.87%
    SZ
    300558
    +0.33%
    © 2026 Longbridge｜Disclaimer